WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001004143) PROSTASE VACCINE
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/004143 International Application No.: PCT/EP2000/006618
Publication Date: 18.01.2001 International Filing Date: 11.07.2000
Chapter 2 Demand Filed: 30.01.2001
IPC:
A61K 39/00 (2006.01) ,C07K 14/11 (2006.01) ,C12N 9/64 (2006.01)
Applicants: CABEZON SILVA, Teresa[BE/BE]; BE (UsOnly)
DILLON, Davin, Clifford[US/US]; US (UsOnly)
SMITHKLINE BEECHAM BIOLOGICALS S.A.[BE/BE]; Rue de l'Institut 89 B-1330 Rixensart, BE (AllExceptUS)
CORIXA CORPORATION[US/US]; 1124 Columbia Street Suite 464 Seattle, WA 98104, US (AllExceptUS)
Inventors: CABEZON SILVA, Teresa; BE
DILLON, Davin, Clifford; US
Agent: DALTON, Marcus, Jonathan, William; SmithKline Beecham Two New Horizons Court Brentford Middlesex TW8 9EP, GB
GIDDINGS , Peter, John; SmithKline Beecham Corporate Intellectual Property Two New Horizons Court Brentford Middlesex TW8 9EP, GB
Priority Data:
0015747.927.06.2000GB
09/352,61613.07.1999US
09/439,31312.11.1999US
09/443,68618.11.1999US
09/483,67214.01.2000US
09/536,85727.03.2000US
09/568,10009.05.2000US
09/570,73712.05.2000US
09/593,79313.06.2000US
09/605,78327.06.2000US
Title (EN) PROSTASE VACCINE
(FR) VACCIN
Abstract:
(EN) The present invention relates to novel proteins and to their production, from the prostase family. In particular, the invention pertains to a prostase protein or fragment thereof fused to an immunological fusion partner, such as NS1. Such antigens may be formulated to provide vaccines for the treatment of prostate tumours. Novel methods for purifying prostase protein and homologues are also provided.
(FR) La présente invention concerne de nouvelles protéines et leur production, à partir de la famille de prostases. En particulier, l'invention a pour objet une protéine de prostase ou un fragment de cette dernière, liée à un partenaire de fusion immunologique, comme le NS1. Ces antigènes peuvent être formulés pour obtenir des vaccins pour traiter des tumeurs de la prostate. L'invention a aussi pour objet de nouveaux procédés permettant de purifier la protéine de prostase et les homologues.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)